Scotiabank raises target for Amgen stock from USD 450.00 to USD 500.00
Scotiabank raises target for Amgen stock from USD 450.00 to USD 500.00 AD HOC NEWS
Covered in this story
Tracked from this story
Scotiabank’s $500 target on $AMGN is on the record and being tracked to Oct 2027 (12-month default), scored on the close that day.
Scotiabank’s track record →Analyst targets on Amgen
- Scotiabank: $424 → $500 by Sep 2027 · Sector Outperform via GuruFocus
- UBS: $408 → $440 by Aug 2027 · Buy via GuruFocus
- Scotiabank: $408 → $450 by Aug 2027 · Outperform via GuruFocus
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $AMGN yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Amgen →Dalsna Finance is currently tracking 50 stories mentioning Amgen, the earliest published 2 Jul 2026.
Summary aggregated from AD HOC NEWS's public RSS feed. The full reporting belongs to AD HOC NEWS — please read it on their site.